AU2012327176B2 - Simethicone formulation - Google Patents

Simethicone formulation Download PDF

Info

Publication number
AU2012327176B2
AU2012327176B2 AU2012327176A AU2012327176A AU2012327176B2 AU 2012327176 B2 AU2012327176 B2 AU 2012327176B2 AU 2012327176 A AU2012327176 A AU 2012327176A AU 2012327176 A AU2012327176 A AU 2012327176A AU 2012327176 B2 AU2012327176 B2 AU 2012327176B2
Authority
AU
Australia
Prior art keywords
simethicone
calcium phosphate
mannitol
weight
phosphate powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2012327176A
Other languages
English (en)
Other versions
AU2012327176A1 (en
Inventor
Hiteshkumar Anilkant Doshi
Vicky SHINDE
Anjali Rajesh TENDULKAR
Jose Luis Velada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Disphar International BV
Original Assignee
Disphar International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Disphar International BV filed Critical Disphar International BV
Publication of AU2012327176A1 publication Critical patent/AU2012327176A1/en
Application granted granted Critical
Publication of AU2012327176B2 publication Critical patent/AU2012327176B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2012327176A 2011-12-14 2012-12-11 Simethicone formulation Ceased AU2012327176B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11193452 2011-12-14
EP11193452.7 2011-12-14
PCT/NL2012/050879 WO2013095111A1 (en) 2011-12-14 2012-12-11 Simethicone formulation

Publications (2)

Publication Number Publication Date
AU2012327176A1 AU2012327176A1 (en) 2013-07-04
AU2012327176B2 true AU2012327176B2 (en) 2015-08-13

Family

ID=47628413

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2012327176A Ceased AU2012327176B2 (en) 2011-12-14 2012-12-11 Simethicone formulation

Country Status (8)

Country Link
US (1) US20150119422A1 (enExample)
EP (1) EP2790676B1 (enExample)
AU (1) AU2012327176B2 (enExample)
BR (1) BR112014014278A2 (enExample)
CA (1) CA2858821A1 (enExample)
IN (1) IN2014MN01382A (enExample)
RU (1) RU2602745C2 (enExample)
WO (1) WO2013095111A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA41620A (fr) 2015-05-14 2018-01-09 Abdi Ibrahim Ilac Sanayi Ve Ticaret A S Composition pharmaceutique comprenant de la siméthicone et de l'otilonium
US20180311201A1 (en) * 2015-06-12 2018-11-01 Santa Farma ?Laç Sanay? A. ?. Oral pharmaceutical composition comprising otilonium bromide and simethicone with certain bulk density and improved dissolution characteristics
MX385008B (es) * 2016-12-14 2025-03-14 Rhein Siegfried Sa De Cv Composicion mejorada de lansoprazol y simeticona y procesos para prepararla.
WO2019165420A1 (en) 2018-02-26 2019-08-29 R.P. Scherer Technologies, Llc Pharmaceutical dosage form for an emulsion of simethicone and loperamide
CN116159032A (zh) * 2023-03-31 2023-05-26 成都恒瑞制药有限公司 盐酸西替利嗪片及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008056200A1 (en) * 2006-11-10 2008-05-15 Ranbaxy Laboratories Limited Oral pharmaceutical compositions of simethicone

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4396604A (en) * 1982-05-17 1983-08-02 Norcliff Thayer, Inc. Simethicone antacid lozenge
US6103260A (en) 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
US6793934B1 (en) 1999-12-08 2004-09-21 Shire Laboratories, Inc. Solid oral dosage form
US7101573B2 (en) 2001-09-28 2006-09-05 Mcneil-Pcc, Inc. Simethicone solid oral dosage form
WO2007057924A1 (en) 2005-11-21 2007-05-24 Panacea Biotec Ltd Laxative composition on the basis of triphala

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008056200A1 (en) * 2006-11-10 2008-05-15 Ranbaxy Laboratories Limited Oral pharmaceutical compositions of simethicone

Also Published As

Publication number Publication date
AU2012327176A1 (en) 2013-07-04
IN2014MN01382A (enExample) 2015-04-17
EP2790676B1 (en) 2018-01-10
BR112014014278A2 (pt) 2017-06-13
RU2602745C2 (ru) 2016-11-20
RU2014128604A (ru) 2016-02-10
US20150119422A1 (en) 2015-04-30
EP2790676A1 (en) 2014-10-22
WO2013095111A1 (en) 2013-06-27
CA2858821A1 (en) 2013-06-27

Similar Documents

Publication Publication Date Title
US6238695B1 (en) Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
US11058671B2 (en) Formulations and methods of manufacturing formulations for use in colonic evacuation
MX2012002789A (es) Tableta antiacida y laxante.
WO2004054574A1 (ja) 経口固形医薬
EP2790676B1 (en) Simethicone formulation
AU2012288632B2 (en) New (trimethoxyphenylamino)pyrimidinyl formulations
JP4689786B2 (ja) 医薬製剤及びその製造方法
EP2514422B1 (en) Elution stabilized teneligliptin preparation
HUE031251T2 (en) Controlled release oral dosage form containing oxycodone
JP6903430B2 (ja) 徐放性製剤
JP6630229B2 (ja) レベチラセタム含有医薬組成物及びその製造方法
RS58214B1 (sr) Farmaceutski sastav koji sadrži kandesartan cileksetil i amlodipin
EP3419605B1 (en) Dasatinib formulation
EA036288B1 (ru) Фармацевтические лекарственные формы
WO2014173515A1 (en) Pharmaceutical composition comprising an atypical antipsychotic agent and method for the preparation thereof
KR102127625B1 (ko) 하이드로모르폰염산염 함유의 경구용 서방성 의약 조성물
AU2011379627A1 (en) Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof
WO2011086577A2 (en) Pharmaceutical composition of moxifloxacin and its pharmaceutically acceptable salts
WO2009063484A2 (en) Stable pharmaceutical composition of lamotrigine
KR20040091135A (ko) 염산 필지카이니드 함유 정제(건식)
EP3173076B1 (en) A pharmaceutical composition comprising simethicone and otilonium
WO2007026261A2 (en) Formulations containing losartan and/or its salts
WO2023067522A1 (en) Pharmaceutical compositions
WO2015106963A1 (en) Pharmaceutical composition comprising aripiprazole or salt thereof
JP2025527261A (ja) 新規製剤

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired